Literature DB >> 6186616

Effect of treatment with interferon and cyclophosphamide on the growth of a spontaneous liposarcoma in rats.

R L Marquet, H Schellekens, D L Westbroek, J Jeekel.   

Abstract

A spontaneous non-immunogenic transplantable liposarcoma in BN rats was found to be sensitive to the antitumor effects of rat fibroblast interferon (RIF) when it was administered from the day of tumor implantation onwards. Treatment with RIF starting at 7 days after implantation was not effective. Tumor growth was markedly inhibited by cyclophosphamide (Cyclo). At the time and dose schedules used, Cyclo was more effective than RIF. When the growth of the tumor was inhibited by Cyclo, subsequent treatment with RIF did not lead to an additional retardation of tumor growth. Administration of RIF interfered with the beneficial effect of Cyclo when both agents were given concomitantly. RIF and Cyclo gave similar results to those obtained with RIF alone and these were inferior to those obtained with Cyclo alone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186616     DOI: 10.1002/ijc.2910310215

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  Combined effect of 5-fluorouracil and interferon on experimental liver metastases of rat colon carcinoma.

Authors:  R L Marquet; J Jeekel
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  Modulation of tumor growth by allogeneic blood transfusion.

Authors:  R L Marquet; R W de Bruin; R J Dallinga; S K Singh; J Jeekel
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

Authors:  P T Nooijen; E R Manusama; A M Eggermont; L Schalkwijk; J Stavast; R L Marquet; R M de Waal; D J Ruiter
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  Site-specific antitumour effects of 2 pyrimidinone compounds in rats.

Authors:  A M Eggermont; R L Marquet; R W De Bruin; W Weimar; J Jeekel
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

5.  A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.

Authors:  A Rohatiner; J Radford; D Deakin; H Earl; S B Love; O Price; A Wilson; T A Lister
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.